Healthy Clinical Trial
Official title:
Assessment of Tongue Protrusion Motor Skills in Healthy Adult
NCT number | NCT06169761 |
Other study ID # | FLEPI |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | December 11, 2023 |
Est. completion date | December 31, 2024 |
This study aims to evaluate tongue protrusion motor skills in healthy adults and to assess the reliability of these measurements as well as their validity in relation to other motor functions (handgrip and respiratory muscles).
Status | Recruiting |
Enrollment | 300 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Being 18 years of age or older Exclusion Criteria: - Eating disorder - Dysphagia - Cardiorespiratory disorder - Previous or ongoing obstructive sleep apnea-hypopnea syndrome - Neurological conditions (including neuromuscular disorders) - Previous or ongoing cancer of the head or neck - Pregnancy - Any physical or mental condition that may affect the ability to consent |
Country | Name | City | State |
---|---|---|---|
Belgium | UCLouvain | Louvain-la-Neuve |
Lead Sponsor | Collaborator |
---|---|
Université Catholique de Louvain |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tongue protrusion peak pressure | Tongue peak pressure during protrusion movements will be measured via the IOPI device | Measured two times: at baseline and after 2 to 4 weeks | |
Primary | Tongue protrusion endurance | Tongue endurance during protrusion movements will be measured via a timer (the time in seconds until the participant is not able to sustain tongue protrusion as controlled via the IOPI). | Measured two times: at baseline and after 2 to 4 weeks | |
Secondary | Tongue elevation peak pressure | Tongue peak pressure during elevation movements will be measured via the IOPI device | Measured two times: at baseline and after 2 to 4 weeks | |
Secondary | Tongue elevation endurance | will be measured via a timer (the time in seconds until the participant is not able to sustain tongue protrusion as controlled via the IOPI). | Measured two times: at baseline and after 2 to 4 weeks | |
Secondary | Tongue mobility restriction | Assessed through the ratio between maximal mouth opening and maximal mouth opening with tongue to palate, measured with the Quick Tongue-Tie Assessment Tool | Measured once at baseline | |
Secondary | Maximum Inspiratory and Expiratory Pressure | Maximum Inspiratory and Expiratory pressure will be measured via the MicroRPM device | Measured once at baseline | |
Secondary | Handgrip Strength | Handgrip Strength will be measured with a JAMAR Hand Dynamometer | Measured once at baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |